Katia Buschiazzo
Varazze,SV
Profilo professionale
After four years of preclinical research experience in oncology, genetics, and molecular biology, with a focus on breast cancer carcinogenesis, I entered the pharmaceutical industry in the sales sector, driven by the desire to better understand the concrete impact of research on patients. As a Specialist Pharmaceutical Sales Representative (ISF Specialist), I have worked across several therapeutic areas, including urology, dermatology, and gynecology, developing a strong scientific background and the skills needed to manage the launch and development of multiple pharmaceutical products, as well as relationships with Key Opinion Leaders (KOLs). I have also gained a deep understanding of stakeholders’ needs, enabling me to transform scientific data into tangible opportunities for clinicians, patients, and the company. I am an ambitious person, strongly goal-oriented, committed to continuous learning, and focused on both professional and personal growth. Currently, I am interested in opportunities as a Product Specialist in highly specialized and innovative therapeutic areas (oncology, rare diseases, advanced therapies) within pharmaceutical or biotech companies, with the aim of contributing to the dissemination of high-impact therapies and the development of corporate strategies.
Panoramica
26
26
anni di esperienza professionale
1
1
Certificato
Esperienza lavorativa
Specialist medical Representative
Pierre Fabre Pharma
2003.09 - 2026.05
- Launch, development, and management of pharmaceutical products with specialist physicians in dermatology and urology. Experience also includes pediatrics, gynecology, respiratory, and vascular areas.
- Launch and development of the new molecule Vibegron for the treatment of OAB, including identification and recruitment of new KOLs in urogynecology, achieving a 29% market share within 3 months.
- Launch and development of 4% fluorouracil for the treatment of actinic keratosis and prevention of non-melanoma skin cancers.
- Development and maintenance of relationships with KOLs.
- Organizer and speaker at 6 hospital meetings over the past year involving hospital urologists and dermatologists.
- Active participation in congresses and CME programs.
- Cross-functional collaboration with Medical Affairs, Marketing, and Market Access teams (One Team Pharma in Action project).
- Generation of strategic insights.
- IMS data analysis and development of strategic action plans to achieve corporate objectives.
- Achievement of 105% of annual sales targets.
- Extension of the lifecycle of a urology product through indication expansion, achieving a 23% market share.
- Market leadership in OAB, BPH, and AK.
Medical Representative
Pharmacia Italia S.p.A., Searle Cardiovascular Division
Savona and Genoa
2003.01 - 2003.08
- Launch, development, and management of pharmaceutical products with general practitioners, cardiologists, neurologists, internists, and pediatricians.
- Celebrex-Solexa co-promotion project carried out in teamwork with 6 pharmaceutical sales lines.
PhD and Research Collaborator
University of Genoa – Department of Oncology, Biology and Genetics (DOBIG), Genetics Laboratory
2002.01 - 2002.12
- Research on metalloproteinases, integrins, and signal transduction in rat osteoblasts and breast cancer cells.
- Research for Omeopiacenza s.r.l. on the effects of homeopathic drug FMS Calciumfluoratum on metalloproteinases and signaling proteins in osteogenesis in vitro.
Research Collaborator
University of Genoa – Department of Health Sciences
2001.10 - 2001.12
- Research on early molecular DNA alterations (DNA adducts, pyrimidine dimers) in carcinogenesis.
Research Collaborator
University of Genoa – Transgenic Unit Laboratory, Advanced Biotechnology Center (CBA)
1999.12 - 2001.09
- Production, characterization, and analysis of transgenic mouse lines for cancer, genetic diseases, and embryogenesis research.
Istruzione
PhD Course - Biology and Genetics
University of Genoa
12.2002
Professional Qualification - Biologist
University of Genoa
Postgraduate Internship - undefined
University of Genoa
09.2001
Master’s Degree - Biological Sciences (Biomolecular)
University of Genoa
04.2001
Classical High School Diploma - undefined
Liceo Classico G. Chiabrera
Savona07.1994
Competenze
- Key Opinion Leader (KOL) engagement and management
- Clinical trials and real-world evidence analysis and presentation
- Scientific Presentation
- Scientific exchange
- Insight generation
- Marketing
- Knowledge of pharmacovigilance, regulatory affairs, ethics
- Launch and management of new drugs
- Scientific expertise in urology, dermatology, and oncology therapeutic areas
- Active participation in scientific and educational events for healthcare professionals (hospital meetings, congresses)
- Public speaking
- Ability to independently manage and organize territory and workload
- Strong analytical, synthesis, and communication skills
- Excellent interpersonal and communication abilities
- Flexibility and adaptability to new work environments and projects
- Team working
- Problem solving
- Cross-functional collaboration
- Ability to prioritize tasks
- Goal-oriented mindset
- High attention to detail
- Emotional intelligence
Certificazioni
- Pharmacovigilance – annual certification (Pierre Fabre Pharma)
- Farmindustria Code of Ethics – annual certification
- Quality / Medical Information – biennial certification
- Stakeholder Management (Alma Laboris Business School) – February 2026
- Regulatory Affairs: Post-marketing variations – February 2026
- AIFA Scientific-Economic Committee hearing preparation – February 2026
- Clinical methodology principles – February 2026
- AI Ethics – November 2025
- Social media best practices – November 2025
- Social engineering and cybersecurity awareness – April 2025
- Healthcare stakeholder engagement – January 2023
- Ethics and compliance in pharma – May 2022
- IT security fundamentals – May 2022
- Code of ethics and conduct – January 2021
- National course on Neuroblastoma – March 21–22, 2002
- Advanced Excel and PowerPoint Course – April 2021
LANGUAGES
Professional working proficiency in English
Native Italian
CONGRESSES
- National and local urology, urooncology, urogynecology, dermatology congresses
- Signal Transduction in Cell Adhesion and Differentiation – Turin (May 2002)
- XXIX SIC Symposium: From Molecular Oncology to Molecular Therapy – Genoa (October 2002)
Cronologia
Specialist medical Representative
Pierre Fabre Pharma
2003.09 - 2026.05
Medical Representative
Pharmacia Italia S.p.A., Searle Cardiovascular Division
2003.01 - 2003.08
PhD and Research Collaborator
University of Genoa – Department of Oncology, Biology and Genetics (DOBIG), Genetics Laboratory
2002.01 - 2002.12
Research Collaborator
University of Genoa – Department of Health Sciences
2001.10 - 2001.12
Research Collaborator
University of Genoa – Transgenic Unit Laboratory, Advanced Biotechnology Center (CBA)
1999.12 - 2001.09
Professional Qualification - Biologist
University of Genoa
Postgraduate Internship - undefined
University of Genoa
Master’s Degree - Biological Sciences (Biomolecular)
University of Genoa
Classical High School Diploma - undefined
Liceo Classico G. Chiabrera
PhD Course - Biology and Genetics
University of Genoa